Panacea Life Sciences Holdings, Inc.

PLSH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Jul 12, 2021
3 Jul 12, 2021
SC 13G Jul 9, 2021
3 Jul 9, 2021 FORM 3
8-K Jul 8, 2021 CURRENT REPORT
8-K Jul 7, 2021 CURRENT REPORT
4/A Jul 6, 2021
4 Jul 6, 2021
4 Jul 2, 2021
4 Jul 2, 2021
8-K Jun 29, 2021 CURRENT REPORT
144 Jun 22, 2021 FORM 144
10-Q/A May 27, 2021 10-Q/A
10-Q May 24, 2021 QUARTERLY REPORT
NT 10-Q May 17, 2021 NT 10-Q
3 May 14, 2021
SC 13D/A May 14, 2021 SCHEDULE 13D/A (AMENDMENT NO. 2)
8-K Apr 30, 2021 CURRENT REPORT
10-K/A Apr 23, 2021 10-K/A
10-K Apr 15, 2021 ANNUAL REPORT
8-K Apr 6, 2021 CURRENT REPORT
NT 10-K Mar 30, 2021
D Feb 18, 2021
8-K Feb 18, 2021 CURRENT REPORT
SC 13D/A Feb 17, 2021 SCHEDULE 13D/A (AMENDMENT NO. 1)
← Newer Page 4 of 13 · 316 filings Older →